Key result
Selective adrenal arterial embolization for primary aldosteronism lacks specific cardiovascular outcome data in this report.
Answers are grounded in this paper and cite their sources.
May improve BP control and CV risk in primary aldosteronism; leaves open confirmation in larger trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Agbedia-Ejughemre et al. (2026) studied this question. Selective adrenal arterial embolization for primary aldosteronism is discussed regarding its cardiovascular effects, though specific clinical findings are not provided in the truncated abstract.
Synapse has enriched 10 related papers. Consider them for comparative context: